Herbert M. Stein
Directeur Général chez Apogee Technology, Inc.
Profil
Herbert M.
Stein is currently the President, CEO, CFO, Secretary & Director at Apogee Technology, Inc. He previously served as the Chairman & Chief Executive Officer at Organogenesis, Inc. from 1987 to 1999.
Postes actifs de Herbert M. Stein
| Sociétés | Poste | Début |
|---|---|---|
Apogee Technology, Inc.
 Apogee Technology, Inc. Medical SpecialtiesHealth Technology Apogee Technology, Inc. is a biotechnology company which develops proprietary systems for the delivery of pharmaceutical agents into the skin for the treatment and prevention of local and systemic conditions. The company was founded in 1987 and is headquartered in Norwood, MA. | Directeur Général | - |
Anciens postes connus de Herbert M. Stein
| Sociétés | Poste | Fin |
|---|---|---|
Organogenesis, Inc.
 Organogenesis, Inc. Medical SpecialtiesHealth Technology Organogenesis, Inc. designs and manufactures regenerative medical products. It offers Apligraf, a living cell-based product indicated for the treatment of venous leg ulcers and diabetic foot ulcers and Dermagraft, a product for the treatment of diabetic foot ulcers. The firm also provides bioactive wound healing, biosurgery, and aesthetic medicine containing living cells and natural connective tissues. The company was founded in 1985 and is headquartered in Canton, MA. | Directeur Général | 01/01/1999 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Apogee Technology, Inc.
Apogee Technology, Inc. Medical SpecialtiesHealth Technology Apogee Technology, Inc. is a biotechnology company which develops proprietary systems for the delivery of pharmaceutical agents into the skin for the treatment and prevention of local and systemic conditions. The company was founded in 1987 and is headquartered in Norwood, MA. | Health Technology |
Organogenesis, Inc.
Organogenesis, Inc. Medical SpecialtiesHealth Technology Organogenesis, Inc. designs and manufactures regenerative medical products. It offers Apligraf, a living cell-based product indicated for the treatment of venous leg ulcers and diabetic foot ulcers and Dermagraft, a product for the treatment of diabetic foot ulcers. The firm also provides bioactive wound healing, biosurgery, and aesthetic medicine containing living cells and natural connective tissues. The company was founded in 1985 and is headquartered in Canton, MA. | Health Technology |
